This e-newsletter is sponsored by
|
Contact Us | |
American Society of
Bariatric Physicians
2821 S. Parker Road Ste. 625
Aurora, CO 80014
303.770.2526 | asbp.org
Staff
Laurie Traetow, CAE
Executive Director
laurie@asbp.org
Beth Amelon Administrative Coordinator
beth@asbp.org
Carly Crosby Administrative Coordinator
carly@asbp.org
Peter Conway
Intern, Marketing & Communications peter@asbp.org
Heidi Gordon
Director of Marketing &
Communications
heidi@asbp.org
|
|
|
Obesity Medicine e-Weekly
|
ASBP report from the 2013 Annual Meeting of the American Medical Association House of Delegates
La st week, I was honored to represent the Society at the American Medical Association (AMA) Annual Meeting of the House of Delegates (HOD). What an important meeting this turned out to be for obesity treatment, as whether or not the AMA should add policy classifying obesity as a chronic disease was a hot topic. The idea that obesity be recognized as a disease by our health care system is one that has been of high priority for the Society. Without this recognition, it is difficult to advance the field of obesity medicine within the medical community. This topic was hotly debated with many arguments both for and against adopting this new policy. I rallied support from my home state of Colorado, as well as from the Western Mountain States Coalition, which resulted in about 20 additional votes in favor of obesity being recognized as a disease by the AMA. The resolution received support from family physicians, pediatricians, surgeons, endocrinologists, OB/GYNs and anesthesiologists. I was able to testify twice on the issue. First, in front of an AMA Reference Committee, I urged recognition of obesity as a chronic disease. Second, I testified in front of the entire AMA House of Delegates. Another society wanted to amend the language to read, "medically complicated obesity." This would really have invalidated the whole resolution. I testified that obesity in and of itself is a disease. It causes harm even in the absence of other medical problems to patients psychologically, physically, functionally and medically. My testimony was supported by the American Academy of Pediatrics, which argued that we should not wait for children to develop type 2 diabetes before addressing their obesity, and by the American Academy of Family Physicians, which suggested it would be a good idea to treat diabetic retinopathy rather than wait for a patient to go blind. Although the Society has had its seat in the AMA House of Delegates since 2001, this is the first time our message has had the opportunity to be heard loud and clear during an AMA meeting. But it was heard, and the resolution passed with 60 percent voting in favor of adopting this new AMA policy!
So, what happens now? Just because the AMA has recognized obesity as a chronic disease, this in and of itself does not guarantee that insurance will start covering treatment. This may still be a long road, but it puts all of us at a critical juncture for our practices and our patients. This meeting clearly showed that the Society can have influence that benefits our patients by working within the AMA. The AMA is a powerful organization and may have the lobbying capability of moving towards insurance coverage. By working together, we can influence our state and specialty medical societies and improve support for furthering our obesity treatment goals. I encourage each member of the Society to consider becoming a member of the AMA. It is important we retain enough doctors who are members of the AMA, or we risk losing our seat in the AMA House of Delegates. If we lose our seat, we lose our ability to influence AMA policy. By working together, we may soon see "obesity parity."
|
News
ASBP member-of badge now available for members to identify with the Society
The Society is pleased to announce a new member benefit: use of the ASBP Member-of logo badge. Now, you may display your affiliation with the Society on marketing collateral, stationery and digital marketing materials! Current members of the Society may click here to be redirected to a log-in web page with terms of usage and download instructions.
Do you have an obesity medicine rotation?
As you are probably already aware, despite our nation being in the midst of an obesity crisis, obesity-specific education and training is still severely lacking in many medical schools and residency programs. In an effort to help students and residents learn more about obesity medicine, the ASBP Medical Students Outreach Task Force is compiling resources for medical students, including a list of physicians who currently offer clinical rotations for medical students and/or residents. If you are currently offering a clinical rotation, please send an e-mail to Administrative Coordinator Carly Crosby so that your name and practice information may be included on the list.
ASBP article featured in June issue of Bariatric Times

The Society is pleased to announce that the June 2013 issue of Bariatric Times features a post-conference article about the recent ASBP biannual conference in San Diego. Click here to read the article. Bariatric Times, a leading peer-reviewed, monthly journal providing articles on clinical developments and metabolic insights in total bariatric patient care, invites you to sign up to receive your complimentary subscription to its digital edition. Visit www.bariatrictimes.com to subscribe. Also, download the Bariatric Times mobile device application and enjoy the evidence-based, peer-reviewed information on bariatric and metabolic medicine wherever and whenever you need it!
|
Resources
Obesity Updates: Click titles to view articles
The Look AHEAD Research Group. NEJM, June 2013.
The Look AHEAD (Action for Health in Diabetes) study was designed to see whether weight loss reduced the risk of heart attacks and strokes among overweight or obese patients with type 2 diabetes. The intervention was stopped on Sept. 14, 2012, on the basis of a futility analysis and recommendation from the data and safety monitoring board. Although the lifestyle intervention group saw no difference in cardiovascular disease compared to the control group, there were many positive health outcomes that came out of the intervention. These results include clinically meaningful improvements in glycated hemoglobin levels; partial remission of diabetes during the first four years of the trial; reductions in urinary incontinence, sleep apnea and depression; and improvements in quality of life, physical functioning and mobility.
Kelly, A.S., et al . JAMA Pediatrics. June 2013.
GLP-1 agonists suppress appetite, but their use has not been verified for the treatment of obesity in adolescents in a clinical study. Researchers from Minnesota evaluated the effects of exenatide on body mass index (BMI) and cardiometabolic-risk factors in adolescents with severe obesity. A three-month, randomized, double-blind, placebo-controlled, multicenter clinical trial was conducted in 26 adolescents (12-19 years of age) with severe obesity (BMI ≥ 1.2 times the 95th percentile or BMI ≥ 35). Results showed that exenatide elicited a greater reduction in BMI and body weight compared with placebo. These results support the use of GLP-1 receptor agonists for the treatment of severe obesity in adolescents.
Blood type diets lack supporting evidence
Cusack, L., et al. AJCN, July 2013. Diets that are based on a person's blood type have been promoted over the past decade and claim to improve health and decrease risk of disease. These health claims have not been substantiated; therefore researchers from Belgium conducted a systematic review of the literature to determine if any evidence exists to support the effectiveness of blood type diets. They found that there is evidence that links an increased vulnerability of certain blood types to particular diseases; however, there is currently no evidence that following blood type diets will provide health benefits, even though there is a considerable amount of blood type diet marketing within the health industry. Until the health effects of blood type diets have been proven, the widespread claims should be clarified so that consumers are aware that the advertised health benefits are theoretical and not supported by scientific evidence.
|
Education
Attend the Obesity Basic Medical Treatment course this Saturday in Milwaukee
The next of the summer Obesity Basic Medical Treatment courses is Saturday, June 29, in Milwaukee, Wis. Attendees earn 7 hours of continuing medical education (CME), plus the second and subsequent registrations from the same office receive a $30 discount. The registration fee is $199, if received by the Wednesday prior to th course or $225 from Thursday to Saturday. The course, presented by the Obesity Medicine Association (a division of the Society), provides basic clinical information and tools to effectively treat patients affected by obesity and related conditions. Click here to learn more, or download a registration form and read details about the course. Online registration is also available for these dates and locations:
- July 13 | Virginia Beach, Va.
- Aug. 3 | Providence, R.I.
Register today for the ASBP 63rd Annual Obesity & Associated Conditions Symposium
|
|
|
|